Top Markets
Coin of the day
Argenica Therapeutics Ltd Argenica Therapeutics Ltd

Argenica Therapeutics Ltd

AGN
Rangering i aksjer #30346
Argenica Therapeutics Limited, a biotechnology company, engages in the research... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Aksjekurs
$0.14599395
Markedsverdi
$18.75M
Endring (1 dag)
0.98%
Endring (1 år)
-67.69%
Land
AU
Handel Argenica Therapeutics Ltd (AGN)

Kategori

Utbytteavkastning for Argenica Therapeutics Ltd (AGN)
Argenica Therapeutics Ltd (aksjesymbol: AGN) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Argenica Therapeutics Ltd (AGN) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter